Optimizing treatment of hepatic metastases from colorectal cancer: Resection or resection plus ablation?

Antonio Chiappa; Emilio Bertani; Andrew P. Zbar; Diego Foschi; Nicola Fazio; Maria Giulia Zampino; Claudio Belluco; Franco Orsi; Paolo Della Vigna; Guido Bonomo; Marco Venturino; Carlo Ferrari; Roberto Biffi

doi:10.3892/ijo.2016.3324

Optimizing treatment of hepatic metastases from colorectal cancer: Resection or resection plus ablation?

Antonio Chiappa, Emilio Bertani, Andrew P. Zbar, Diego Foschi, Nicola Fazio, Maria Giulia Zampino, Claudio Belluco, Franco Orsi, Paolo Della Vigna, Guido Bonomo, Marco Venturino, Carlo Ferrari, Roberto Biffi

Research output: Contribution to journal › Article › peer-review

Abstract

The present study determines the oncologic outcome of the combined resection and ablation strategy for colorectal liver metastases (CRLM). Between January 1994 and December 2014, 360 patients underwent surgery for CRLM. There were 280 patients who underwent hepatic resection only (group 1) and 80 hepatic resection plus ablation (group 2). group 2 patients had a higher incidence of multiple metastases than group 1 cases (100% in group 2 vs. 28.2% in group 1; P

Original language	English
Pages (from-to)	1280-1289
Number of pages	10
Journal	International Journal of Oncology
Volume	48
Issue number	3
DOIs	https://doi.org/10.3892/ijo.2016.3324
Publication status	Published - Mar 1 2016

Keywords

Colorectal cancer
Cryosurgical ablation
Hepatic metastases
Liver resection
Radiofrequency ablation

ASJC Scopus subject areas

Cancer Research
Oncology

Access to Document

10.3892/ijo.2016.3324

Fingerprint Dive into the research topics of 'Optimizing treatment of hepatic metastases from colorectal cancer: Resection or resection plus ablation?'. Together they form a unique fingerprint.

Cite this

Chiappa, A., Bertani, E., Zbar, A. P., Foschi, D., Fazio, N., Zampino, M. G., Belluco, C., Orsi, F., Della Vigna, P., Bonomo, G., Venturino, M., Ferrari, C., & Biffi, R. (2016). Optimizing treatment of hepatic metastases from colorectal cancer: Resection or resection plus ablation? International Journal of Oncology, 48(3), 1280-1289. https://doi.org/10.3892/ijo.2016.3324

Optimizing treatment of hepatic metastases from colorectal cancer : Resection or resection plus ablation? / Chiappa, Antonio ; Bertani, Emilio; Zbar, Andrew P.; Foschi, Diego; Fazio, Nicola ; Zampino, Maria Giulia ; Belluco, Claudio ; Orsi, Franco ; Della Vigna, Paolo ; Bonomo, Guido; Venturino, Marco; Ferrari, Carlo; Biffi, Roberto.

In: International Journal of Oncology, Vol. 48, No. 3, 01.03.2016, p. 1280-1289.

Research output: Contribution to journal › Article › peer-review

Chiappa, Antonio ; Bertani, Emilio ; Zbar, Andrew P. ; Foschi, Diego ; Fazio, Nicola ; Zampino, Maria Giulia ; Belluco, Claudio ; Orsi, Franco ; Della Vigna, Paolo ; Bonomo, Guido ; Venturino, Marco ; Ferrari, Carlo ; Biffi, Roberto. / Optimizing treatment of hepatic metastases from colorectal cancer : Resection or resection plus ablation?. In: International Journal of Oncology. 2016 ; Vol. 48, No. 3. pp. 1280-1289.

@article{cfe9605a504d418ca50ea84b91f5e810,

title = "Optimizing treatment of hepatic metastases from colorectal cancer: Resection or resection plus ablation?",

abstract = "The present study determines the oncologic outcome of the combined resection and ablation strategy for colorectal liver metastases (CRLM). Between January 1994 and December 2014, 360 patients underwent surgery for CRLM. There were 280 patients who underwent hepatic resection only (group 1) and 80 hepatic resection plus ablation (group 2). group 2 patients had a higher incidence of multiple metastases than group 1 cases (100% in group 2 vs. 28.2% in group 1; P",

keywords = "Colorectal cancer, Cryosurgical ablation, Hepatic metastases, Liver resection, Radiofrequency ablation",

author = "Antonio Chiappa and Emilio Bertani and Zbar, {Andrew P.} and Diego Foschi and Nicola Fazio and Zampino, {Maria Giulia} and Claudio Belluco and Franco Orsi and {Della Vigna}, Paolo and Guido Bonomo and Marco Venturino and Carlo Ferrari and Roberto Biffi",

year = "2016",

month = mar,

day = "1",

doi = "10.3892/ijo.2016.3324",

language = "English",

volume = "48",

pages = "1280--1289",

journal = "International Journal of Oncology",

issn = "1019-6439",

publisher = "Spandidos Publications",

number = "3",

}

TY - JOUR

T1 - Optimizing treatment of hepatic metastases from colorectal cancer

T2 - Resection or resection plus ablation?

AU - Chiappa, Antonio

AU - Bertani, Emilio

AU - Zbar, Andrew P.

AU - Foschi, Diego

AU - Fazio, Nicola

AU - Zampino, Maria Giulia

AU - Belluco, Claudio

AU - Orsi, Franco

AU - Della Vigna, Paolo

AU - Bonomo, Guido

AU - Venturino, Marco

AU - Ferrari, Carlo

AU - Biffi, Roberto

PY - 2016/3/1

Y1 - 2016/3/1

N2 - The present study determines the oncologic outcome of the combined resection and ablation strategy for colorectal liver metastases (CRLM). Between January 1994 and December 2014, 360 patients underwent surgery for CRLM. There were 280 patients who underwent hepatic resection only (group 1) and 80 hepatic resection plus ablation (group 2). group 2 patients had a higher incidence of multiple metastases than group 1 cases (100% in group 2 vs. 28.2% in group 1; P

AB - The present study determines the oncologic outcome of the combined resection and ablation strategy for colorectal liver metastases (CRLM). Between January 1994 and December 2014, 360 patients underwent surgery for CRLM. There were 280 patients who underwent hepatic resection only (group 1) and 80 hepatic resection plus ablation (group 2). group 2 patients had a higher incidence of multiple metastases than group 1 cases (100% in group 2 vs. 28.2% in group 1; P

KW - Colorectal cancer

KW - Cryosurgical ablation

KW - Hepatic metastases

KW - Liver resection

KW - Radiofrequency ablation

UR - http://www.scopus.com/inward/record.url?scp=84958999170&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84958999170&partnerID=8YFLogxK

U2 - 10.3892/ijo.2016.3324

DO - 10.3892/ijo.2016.3324

M3 - Article

VL - 48

SP - 1280

EP - 1289

JO - International Journal of Oncology

JF - International Journal of Oncology

SN - 1019-6439

IS - 3

ER -